Watch CELZ. Know when insiders buy.
One email the day a filing lands. Free.
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
1.04
−0.04 −3.70%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $6.9MP/E —DIV YIELD —FCF YIELD —REV TTM $3K −50.0%NET INCOME −$6MNET DEBT $639K52W 0.65 – 5.59SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $0 | — | — | −$1.6M | −$1.5M | — | -0.41 | −$1.5M | — | — | Aug 7 |
| Q1 2026 · Mar 31 | $0 | −100.0% | — | −$1.5M | −$1.4M | — | -0.38 | −$1.3M | — | — | May 8 |
| Q4 2025 · Dec 31derived | $3K | +0.0% | 66.9% | −$1.9M | −$1.9M | — | -0.80 | −$1.9M | — | — | Mar 20 |
| Q3 2025 · Sep 30 | $0 | — | — | −$1.3M | −$1.2M | — | -0.48 | −$1.2M | — | — | Nov 7 |
| Q2 2025 · Jun 30 | $0 | −100.0% | — | −$1.3M | −$1.2M | — | -0.48 | −$1.2M | — | — | Aug 7 |
| Q1 2025 · Mar 31 | $3K | — | 60.0% | −$1.7M | −$1.6M | — | -0.83 | −$1.6M | — | — | May 8 |
| Q4 2024 · Dec 31derived | $3K | +0.0% | 60.0% | −$1.9M | −$1.9M | — | -1.12 | −$1.9M | — | — | Mar 20 |
| Q3 2024 · Sep 30 | $0 | −100.0% | — | −$1.1M | −$1M | — | -0.75 | −$986K | — | — | Nov 7 |
| Q2 2024 · Jun 30 | $8K | — | 60.0% | −$1.6M | −$1.6M | — | -1.11 | −$1.5M | — | — | Aug 8 |
| Q1 2024 · Mar 31 | $0 | — | — | −$1.1M | −$1M | — | 0.73 | −$897K | — | — | May 9 |
| Q4 2023 · Dec 31derived | $3K | — | 60.0% | −$1.8M | −$1.7M | — | — | −$1.9M | — | — | Mar 14 |
| Q3 2023 · Sep 30 | $6K | — | 60.0% | −$1.5M | −$1.5M | — | — | −$1.3M | — | — | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $6K | 63.4% | −$6.1M | −$6M | -99916.8% | -2.52 | −$5.9M | — | — | $10K | — |
| FY2024 · to Dec 31 | $11K | 60.0% | −$5.7M | −$5.5M | -49940.7% | -3.71 | −$5.3M | — | — | $175K | — |
| FY2023 · to Dec 31 | $9K | 60.0% | −$5.6M | −$5.3M | -58739.7% | -3.76 | −$8M | — | — | $271K | — |
| FY2022 · to Dec 31 | $89K | 67.8% | −$10.2M | −$10.1M | -11449.3% | -0.93 | −$7.8M | — | — | $0 | — |
| FY2021 · to Dec 31 | $88K | 45.4% | −$3.1M | $19.2M | 21892.8% | 5.61 | −$2.2M | — | — | — | — |
| FY2020 · to Dec 31 | $165K | 69.2% | −$1.1M | −$36.3M | -22082.2% | -62.69 | −$435K | — | — | — | — |
Every number comes from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.